TrialAIDS research and human retroviruses2013

Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.

Amy C Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.